BAY CITY CAPITAL LLC

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$16.13M
Insider Sells Quantity
12
Insider Sells Sum
$267.04M

Insider Activity of BAY CITY CAPITAL LLC

The largest purchase of all time was on 2010-06-30 and amounted to 23824450 shares of Viracta Therapeutics, Inc. for $6.55M.

The largest sale of all time was on 2019-12-13 and amounted to 1200000 shares of Madrigal Pharmaceuticals, Inc. for $126.56M.

Biography of BAY CITY CAPITAL LLC

No biography is available at this moment.

2021-10-26PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
312,500
1.1398%
$16.00$5M-76.08%
2020-08-19SaleMadrigal Pharmaceuticals, Inc.
MDGL
10 percent owner
7,303
0.0475%
$107.64$786,095+9.17%
2020-08-18SaleMadrigal Pharmaceuticals, Inc.
MDGL
10 percent owner
10,197
0.0666%
$110.03$1.12M+7.24%
2020-08-17SaleMadrigal Pharmaceuticals, Inc.
MDGL
10 percent owner
12,500
0.0806%
$110.73$1.38M+5.17%
2019-12-13SaleMadrigal Pharmaceuticals, Inc.
MDGL
10 percent owner
1.2M
8.4176%
$105.47$126.56M+8.9%
2018-06-25PurchaseKezar Life Sciences, Inc.
KZR
10 percent owner
300,000
12.8369%
$15.00$4.5M+15.16%
2018-06-11SaleMadrigal Pharmaceuticals, Inc.
MDGL
280,000
2.0429%
$287.46$80.49M-50.82%
2015-07-24SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
635,702
3.0672%
$3.46$2.2M-15.63%
2015-06-08SaleNevro Corp.
NVRO
983,670
3.8868%
$47.94$47.16M+15.28%
2014-08-28SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
200,000
0.3348%
$7.89$1.58M-69.28%
2014-08-27SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
100,700
0.165%
$8.16$822,014-70.96%
2014-08-12SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
37,100
0.0616%
$6.77$251,230-63.95%
2014-08-11SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
31,600
0.0523%
$6.90$218,103-64.73%
2014-08-08SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
675,000
1.1015%
$6.62$4.47M-63.58%
2010-06-30PurchaseViracta Therapeutics, Inc.
VIRX
10 percent owner
23.82M
6.2843%
$0.28$6.55M-14.89%
2009-10-30PurchaseViracta Therapeutics, Inc.
VIRX
10 percent owner
333,166
–
$0.22$73,297+62.16%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.